Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Top-Institutions - MDSpire

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Nephrology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Nephrology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Nephrology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Cardiology

Original Source(s)

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

Related Content

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

Editorial: Addressing the Challenges of Diabetes Complications and Exploring Innovative Approaches

Detection of Referable Diabetic Retinopathy using Machine Learning on Routine Clinical Data